Published in J Leukoc Biol on September 01, 1998
Cancer immunotherapy via dendritic cells. Nat Rev Cancer (2012) 5.37
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med (2009) 4.27
Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med (2000) 2.69
Designing vaccines based on biology of human dendritic cell subsets. Immunity (2010) 2.04
Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol (2001) 1.92
Interactions of tumor cells with dendritic cells: balancing immunity and tolerance. Cell Death Differ (2007) 1.35
Safety and efficacy of combination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanoma. J Clin Oncol (2011) 1.24
Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169. PLoS Pathog (2013) 1.19
Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma. Blood (2010) 1.17
How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets. Immunol Rev (2008) 1.15
IFN-α in the treatment of melanoma. J Immunol (2012) 1.12
Human dendritic cell subsets for vaccination. J Clin Immunol (2005) 1.09
Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis. J Exp Med (2005) 1.07
Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. J Transl Med (2007) 1.04
Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing. J Immunol (2012) 1.04
North American porcine reproductive and respiratory syndrome viruses inhibit type I interferon production by plasmacytoid dendritic cells. J Virol (2010) 1.00
Dendritic cells: a critical player in cancer therapy? J Immunother (2008) 0.99
Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation. Immunology (2003) 0.97
CD20-targeted tetrameric interferon-alpha, a novel and potent immunocytokine for the therapy of B-cell lymphomas. Blood (2009) 0.96
Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity. Front Immunol (2013) 0.95
Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient mice. J Immunol (2009) 0.92
Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation. Immunology (2007) 0.91
Targeting to porcine sialoadhesin receptor improves antigen presentation to T cells. Vet Res (2008) 0.88
Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host. Biology (Basel) (2013) 0.86
Interferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into dendritic cell-like cells. Arthritis Res Ther (2008) 0.85
Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity. Clin Exp Immunol (2005) 0.83
Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity. Clin Dev Immunol (2009) 0.81
Synergistic effects of interferon-alpha in combination with chemoradiation on human pancreatic adenocarcinoma. World J Gastroenterol (2005) 0.81
Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1. Scientifica (Cairo) (2013) 0.80
Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells. Br J Dermatol (2008) 0.80
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma. J Transl Med (2015) 0.78
Combination of IFN-α/Gm-CSF as a Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (ASCT): A Prospective Phase II Study. Clin Med Insights Oncol (2010) 0.78
Monocyte-derived dendritic cells: a potential target for therapy in multiple sclerosis (MS). Clin Exp Immunol (2001) 0.78
Combination immunotherapy: a road map. J Immunother Cancer (2017) 0.77
Effectiveness of electrochemotherapy after IFN-α adjuvant therapy of melanoma patients. Radiol Oncol (2016) 0.77
Immune checkpoint blockade and interferon-α in melanoma. Semin Oncol (2015) 0.77
Differential activity of type I interferon subtypes for dendritic cell differentiation. PLoS One (2013) 0.77
Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha. BMC Immunol (2008) 0.77
The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development. Cancer Immunol Res (2015) 0.76
Effect of Mucosal Cytokine Administration on Selective Expansion of Vaginal Dendritic Cells to Support Nanoparticle Transport. Am J Reprod Immunol (2015) 0.76
Advances in cellular therapy for the treatment of thyroid cancer. J Oncol (2010) 0.76
Type I interferons as regulators of human antigen presenting cell functions. Toxins (Basel) (2014) 0.76
The use of immunotherapy in the treatment of melanoma. J Hematol Oncol (2017) 0.75
Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection. J Interferon Cytokine Res (2016) 0.75
Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of IFN-α. J Virol (2017) 0.75
Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment. Front Endocrinol (Lausanne) (2017) 0.75
Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst (1998) 2.34
Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest (1997) 2.28
Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol (2001) 2.24
Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases. J Bacteriol (1991) 1.82
Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol (2000) 1.77
Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo. Leukemia (2002) 1.71
Conservation therapy for invasive lobular carcinoma of the breast. Cancer (1992) 1.67
Childhood-onset schizophrenia: progressive brain changes during adolescence. Biol Psychiatry (1999) 1.66
Chronic lymphocytic leukemia and the central nervous system: a clinical and pathological study. Neurology (1996) 1.66
Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer. J Natl Cancer Inst (1997) 1.62
Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy. Cancer J Sci Am (1998) 1.53
In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2. Hum Gene Ther (1997) 1.53
Major salivary gland tumors: treatment results and prognostic factors. Laryngoscope (1986) 1.45
Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol (2000) 1.44
Postoperative irradiation for the prevention of heterotopic bone: analysis of different dose schedules and shielding considerations. Int J Radiat Oncol Biol Phys (1990) 1.42
Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. J Virol (1998) 1.41
Postoperative radiation therapy after radical prostatectomy for prostate carcinoma. Cancer (1992) 1.38
Fifteen-year global time series of satellite-derived fine particulate matter. Environ Sci Technol (2014) 1.37
Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J Neuroimmunol (1998) 1.29
T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein. J Immunol (2001) 1.28
Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma. Cancer Res (1999) 1.28
Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein. Cancer Res (1999) 1.26
A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther (1997) 1.25
Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res (1997) 1.22
Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J Leukoc Biol (1996) 1.20
Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J Immunol (2000) 1.20
Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. Urology (2001) 1.16
Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr (1993) 1.15
Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3-deficient mice. J Immunol (1998) 1.14
Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am J Respir Crit Care Med (1997) 1.11
Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus. J Immunol (1998) 1.10
Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids. Am J Respir Cell Mol Biol (1999) 1.09
alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination. Cancer Res (2001) 1.07
Whole body skeletal imaging with [18F]fluoride ion and PET. J Comput Assist Tomogr (1993) 1.07
Function of steroidogenic factor 1 domains in nuclear localization, transactivation, and interaction with transcription factor TFIIB and c-Jun. Mol Endocrinol (1999) 1.06
A comparison of mixed effects logistic regression models for binary response data with two nested levels of clustering. Stat Med (1999) 1.05
Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET. J Comput Assist Tomogr (1992) 1.05
Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing. Food Chem Toxicol (2000) 1.04
Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. J Nucl Med (1998) 1.02
Concentrations of high-mobility-group proteins in the nucleus and cytoplasm of several rat tissues. J Cell Biol (1984) 1.02
Antimicrobial and respiratory burst characteristics of pulmonary alveolar macrophages recovered from smokers of marijuana alone, smokers of tobacco alone, smokers of marijuana and tobacco, and nonsmokers. Am Rev Respir Dis (1991) 1.00
Fibrosarcoma of the head and neck. The UCLA experience. Arch Otolaryngol Head Neck Surg (1991) 0.99
Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein. Mol Immunol (2000) 0.98
p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma. Cancer Res (1999) 0.97
Osteogenic sarcoma of the head and neck. The UCLA experience. Arch Otolaryngol Head Neck Surg (1991) 0.97
Accumulation of the F plasmid TraJ protein in cpx mutants of Escherichia coli. J Bacteriol (1993) 0.95
Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF. Cytometry (1995) 0.95
Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer (1993) 0.94
Low-dose, time-resolved, contrast-enhanced 3D MR angiography in cardiac and vascular diseases: correlation to high spatial resolution 3D contrast-enhanced MRA. Clin Radiol (2008) 0.91
Synthesis and cleavage of oligodeoxynucleotides containing a 5-hydroxyuracil residue at a defined site. Chem Res Toxicol (1997) 0.91
Tissue-specific, hormonal, and developmental regulation of SCC-LacZ expression in transgenic mice leads to adrenocortical zone characterization. Endocrinology (1999) 0.91
Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor. Am J Dis Child (1991) 0.90
The responses of neurons in subdivisions of the inferior colliculus of cats to tonal, noise and vocal stimuli. Exp Brain Res (1994) 0.90
Marijuana smoking, pulmonary function, and lung macrophage oxidant release. Pharmacol Biochem Behav (1991) 0.90
CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells. Cancer Res (2001) 0.90
Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood (1991) 0.89
Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant (1998) 0.89
Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells. Cancer Gene Ther (2000) 0.88
Distant metastasis in triple-negative breast cancer. Neoplasma (2013) 0.88
Sarcomas of the nasal cavity and paranasal sinuses. Ann Otol Rhinol Laryngol (1994) 0.88
Erythrocytic pyruvate kinase deficiency and AB blood types in Australian Abyssinian and Somali cats. Aust Vet J (2009) 0.87
Age-related changes in trabecular cells in vitro. Exp Eye Res (1997) 0.87
Effects of smoking marijuana, tobacco or cocaine alone or in combination on DNA damage in human alveolar macrophages. Life Sci (1995) 0.86
Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells. J Immunother (2000) 0.86
The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Ann Surg (1992) 0.86
Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL. Gene Ther (2004) 0.85
Importance of stress receptor-mediated mechanisms in the amygdala on visceral pain perception in an intrinsically anxious rat. Neurogastroenterol Motil (2012) 0.84
Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients. Cancer Res (2000) 0.84
Oxidative stress specifically downregulates survivin to promote breast tumour formation. Br J Cancer (2013) 0.83
Functions of the upstream and proximal steroidogenic factor 1 (SF-1)-binding sites in the CYP11A1 promoter in basal transcription and hormonal response. Mol Endocrinol (2001) 0.83
Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine (Lond) (2009) 0.83
The common I172N mutation causes conformational change of cytochrome P450c21 revealed by systematic mutation, kinetic, and structural studies. J Biol Chem (1996) 0.83
A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients. Blood (1999) 0.82
Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer. Am J Clin Oncol (2000) 0.81
The impact of granulocyte colony-stimulating factor on quality of life in patients with severe chronic neutropenia. Oncol Nurs Forum (1992) 0.81
Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice. Cancer Res (2000) 0.81
Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Bone Marrow Transplant (1998) 0.81
Taste disorders in Australian Aboriginal and non-Aboriginal children. Acta Paediatr (2011) 0.81
Organochlorine pesticide content of breast adipose tissue from women with breast cancer and control subjects. J Natl Cancer Inst (2000) 0.80
Marijuana smoke and Delta(9)-tetrahydrocannabinol promote necrotic cell death but inhibit Fas-mediated apoptosis. Toxicol Appl Pharmacol (2001) 0.80
Hyperammonemia following allogeneic bone marrow transplantation. Am J Hematol (1991) 0.80
Hepatitis C virus infection in acquired aplastic anemia. Am J Hematol (1998) 0.80
Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity. Cancer Gene Ther (1997) 0.80
Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines. J Nucl Med (1995) 0.80
Regulation of steroidogenesis in transgenic mice and zebrafish. Mol Cell Endocrinol (2001) 0.79
Reduced association of anti-apoptotic protein Mcl-1 with E3 ligase Mule increases the stability of Mcl-1 in breast cancer cells. Br J Cancer (2011) 0.79
Regulation of natural killer function by nonlymphoid cells. Nat Immun (1994) 0.79
Expression of CD45 isoforms in fresh and IL-2-cultured tumor-infiltrating lymphocytes from basal cell carcinoma. Cell Immunol (1993) 0.79
A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density. Calcif Tissue Int (2003) 0.78
Model-free sib-pair linkage analysis: combining full-sib and half-sib pairs. Genet Epidemiol (2000) 0.78
Function and membrane topology of wild-type and mutated cytochrome P-450c21. Biochem J (1996) 0.78